Global Preterm Birth and Premature Rupture Of Membranes (PROM) Testing Market, By Test Type (Pelvic Exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling) End User Industry (Hospitals and Clinical Laboratories), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Preterm Birth and Premature Rupture of Membranes (PROM) Testing Market
Data Bridge Market Research analyses that the preterm birth and premature rupture of membranes (PROM) testing market to growing at a CAGR of 4.20% in the forecast period of 2022-2029.
Premature rupture of membranes (PROM) is a rupture (breaking open) of the membranes (amniotic sac) prior to the onset of labour. PROM is known as preterm premature rupture of membranes if it occurs before 37 weeks of pregnancy (PPROM). PROM occurs in approximately 8 to 10% of all pregnancies. PPROM (preterm birth before 37 weeks) accounts for one-fourth to one-third of all preterm births.
Over the forecast period, key factors that can be attributed to market growth include an increase in the number of preterm births in developed and emerging economies, improved access to advanced neonatal and maternal care facilities, and the introduction of new point-of-care diagnostic products. Companies are investing in research and development activities to improve the specificity and sensitivity of their devices and lowering the error rate.
As a result, emphasis is being placed on reducing the sample size required for other medical testing, which will contribute to market growth. The increase in the purchase of biomarker test kits is expected to drive the market over the forecast period. Increasing demand for better healthcare, rising treatment costs, and a growing global population are expected to drive the market for point-of-care testing, boosting the adoption of preterm birth and premature rupture of membranes (PROM) testing.
However, some of the factors that may have an impact on the global preterm birth and premature rupture of membranes (PROM) testing market include a lack of experienced professionals and strict regulatory agencies. Eliminating the inconvenience caused to patients by regular check-ups and tests can be a market challenge for its growth.
This preterm birth and premature rupture of membranes (PROM) testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on preterm birth and premature rupture of membranes (PROM) testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Preterm Birth and Premature Rupture of Membranes (PROM) Testing Market Scope and Market Size
The preterm birth and premature rupture of membranes (PROM) testing market is segmented on the basis of test type and end-user industry. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of test type, the preterm birth and premature rupture of membranes (PROM) testing market is segmented into pelvic exam, ultrasound, biochemical markers, uterine monitoring, nitazine test, ferning test and pooling. Biochemical markers is further segmented into Interleukin (IL)-6 , c-reactive protein (CRP) , IL-1, IL-2, IL-8, TNF-a , corticotropin-releasing hormone (CRH) and alpha-fetoprotein (AFP)
- On the basis of end-user, the preterm birth and premature rupture of membranes (PROM) testing market is segmented into hospitals and clinical laboratories.
Preterm Birth and Premature Rupture of Membranes (PROM) Testing Market Country Level Analysis
The preterm birth and premature rupture of membranes (PROM) testing market is analysed and market size insights and trends are provided by country, test type and end-user industry as referenced above.
The countries covered in the preterm birth and premature rupture of membranes (PROM) testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is dominating the preterm birth and premature rupture of membranes (PROM) testing market due to the rising pregnancies cases of woman over 35 years of age as well as there is a well-developed infrastructure to manage high-risk pregnancies. Asia-Pacific region is expected to lead the global medical device calibration market during the forecast period due to the rising population in countries like India and China.
The country section of the preterm birth and premature rupture of membranes (PROM) testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The preterm birth and premature rupture of membranes (PROM) testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for preterm birth and premature rupture of membranes (PROM) testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the preterm birth and premature rupture of membranes (PROM) testing market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Preterm birth and Premature Rupture of Membranes (PROM) Testing Market Share Analysis
The preterm birth and premature rupture of membranes (PROM) testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to preterm birth and Premature rupture of membranes (PROM) testing market.
Some of the major players operating in the preterm birth and premature rupture of membranes (PROM) testing market are CooperSurgical, Inc., Medtronic, Fisher & Paykel Healthcare Limited, FUJIFILM Holdings Corporation, Nonin, Getinge AB, General Electric, Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA, Natus Medical Incorporated, miracradle, Inspiration Healthcare Group plc, Abbott, Analogic Corporation, Atom Medical Corp., Arjo, BD, Hamilton Medical, Masimo, Medela AG and NIHON KOHDEN COPORATION, among others.
SKU-
